latest tirzepatide news Eli Lilly sues companies selling alternative versions of its weight loss drug Compounded versions of tirzepatide (Mounjaro,

Amgen's experimental drug contains a monoclonal antibody that helps it stay in the body longer.

This article explores current clinical evidence, provider decision-making frameworks, and how genetic insights may inform a personalized conversation with your healthcare

Insulin resistance and chronic hyperglycemia cause a cascade of pathological events in the brain, including neuroinflammation, impaired neurotransmitter systems and energy metabolism, oxidative stress, and vascular pathologies that ultimately lead to neurodegeneration, loss of synaptic plasticity, brain aging, cognitive impairment, and dementia

The science behind 24% weight loss results explained.

Weight Watcher's new CMO Nina George is working to distinguish the brand as a leader in the crowded GLP-1 field.

After 40 weeks, the blood sugar levels of people receiving the drug had dropped by between 1.7% and 1.9% compared with 0.8% for people receiving a placebo